CANOC

BC-CfE study examines how neighbourhood poverty affects those living with HIV

Uncategorized / By

A recently published study by BC-CfE researchers titled Neighbourhood-level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort (CANOC): a longitudinal cohort studyexamines the relationship between a neighbourhood’s socioeconomic status and how this affects the lives and health of Canadians living with HIV who are on combination antiretroviral therapy (ART).

BC-CfE study examines how neighbourhood poverty affects those living with HIV Read More »

CANOC fact sheet: Learn about the largest nationwide study of people living with HIV on treatment

Uncategorized / By

This week, we are sharing a fact sheet on the Canadian Observational Cohort (CANOC): Canada’s largest multi-province study of people living with HIV on antiretroviral therapy. CANOC is an integrated network of all registered treatment information from eleven cohort databases across British Columbia, Ontario, Quebec, Saskatchewan and Newfoundland. This collaboration of national researchers and select databases establishes policy-relevant studies in HIV therapeutics, population and public health.

CANOC fact sheet: Learn about the largest nationwide study of people living with HIV on treatment Read More »

CANOC (Canadian HIV Observational Cohort Collaborative Research Centre) Fact Sheet

By

Download the CANOC fact sheet CANOC is an initiative of the BC-CfE’sEpidemiology and Population Health Program. It is an integrated network of all registered treatment information from eleven cohort databases across British Columbia, Ontario, Quebec, Saskatchewan and Newfoundland. This collaboration of national researchers and select databases establishes policy-relevant studies in HIV therapeutics, population and public

CANOC (Canadian HIV Observational Cohort Collaborative Research Centre) Fact Sheet Read More »

Manulife to offer life insurance to HIV-positive Canadians for 1st time

By

As life expectancy for HIV-positive people rises, it is seen as chronic illness that is manageable Manulife has become the first Canadian insurance company to offer life insurance to people who are HIV-positive. In a release Friday, the insurance conglomerate said it made the decision after it reviewed the latest mortality and long-term survival rates

Manulife to offer life insurance to HIV-positive Canadians for 1st time Read More »

Canadian Researchers Call for Public Health Strategy to Improve Engagement in HIV Care

By

Over the past decade, evidence has been accumulating that starting potent combination anti-HIV therapy (commonly called ART) as early as possible in the course of HIV disease is beneficial. The evidence trend culminated in the summer of 2015 with the release of the results from the START clinical trial. In that large well-designed study, researchers

Canadian Researchers Call for Public Health Strategy to Improve Engagement in HIV Care Read More »

Stemming an Epidemic

By

Robert Hogg focuses on identifying ongoing health inequities among vulnerable HIV-positive populations to better meet their unique health care needs. Since the early 1990s, SFU professor of health sciences Dr. Robert Hogg has been conducting demographic research on British Columbia’s HIV-positive population. With an eye towards influencing health policy decisions and improving health outcomes, his

Stemming an Epidemic Read More »

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

Start typing and press enter to search